Atjaunināt sīkdatņu piekrišanu

E-grāmata: Asthma: Basic Mechanisms and Clinical Management

Edited by (Head of Respiratory Medicine, Imperial College, London, UK, Airway Disease Section, National Heart and Lung Institute), Edited by (Merck Frosst Canada Inc., Point Claire-Dorval, Quebec, Canada), Edited by (Western Infirmary, Glasgow, Scotland)
  • Formāts: PDF+DRM
  • Izdošanas datums: 20-Apr-1998
  • Izdevniecība: Academic Press Inc
  • Valoda: eng
  • ISBN-13: 9780080525525
Citas grāmatas par šo tēmu:
  • Formāts - PDF+DRM
  • Cena: 243,88 €*
  • * ši ir gala cena, t.i., netiek piemērotas nekādas papildus atlaides
  • Ielikt grozā
  • Pievienot vēlmju sarakstam
  • Šī e-grāmata paredzēta tikai personīgai lietošanai. E-grāmatas nav iespējams atgriezt un nauda par iegādātajām e-grāmatām netiek atmaksāta.
  • Formāts: PDF+DRM
  • Izdošanas datums: 20-Apr-1998
  • Izdevniecība: Academic Press Inc
  • Valoda: eng
  • ISBN-13: 9780080525525
Citas grāmatas par šo tēmu:

DRM restrictions

  • Kopēšana (kopēt/ievietot):

    nav atļauts

  • Drukāšana:

    nav atļauts

  • Lietošana:

    Digitālo tiesību pārvaldība (Digital Rights Management (DRM))
    Izdevējs ir piegādājis šo grāmatu šifrētā veidā, kas nozīmē, ka jums ir jāinstalē bezmaksas programmatūra, lai to atbloķētu un lasītu. Lai lasītu šo e-grāmatu, jums ir jāizveido Adobe ID. Vairāk informācijas šeit. E-grāmatu var lasīt un lejupielādēt līdz 6 ierīcēm (vienam lietotājam ar vienu un to pašu Adobe ID).

    Nepieciešamā programmatūra
    Lai lasītu šo e-grāmatu mobilajā ierīcē (tālrunī vai planšetdatorā), jums būs jāinstalē šī bezmaksas lietotne: PocketBook Reader (iOS / Android)

    Lai lejupielādētu un lasītu šo e-grāmatu datorā vai Mac datorā, jums ir nepieciešamid Adobe Digital Editions (šī ir bezmaksas lietotne, kas īpaši izstrādāta e-grāmatām. Tā nav tas pats, kas Adobe Reader, kas, iespējams, jau ir jūsu datorā.)

    Jūs nevarat lasīt šo e-grāmatu, izmantojot Amazon Kindle.

Brings together recent information on basic mechanisms of asthma and also covers clinical aspects and therapy in depth. Coverage includes epidemiology, genetics, airway smooth muscle cells, lymphocytes, epithelial cells, adhesion molecules, prostaglandins and thromboxane, pathophysiology of asthma, occupational asthma, atmospheric pollutants, and pharmacoeconomics of asthma treatments. For basic researchers and clinicians. This third edition incorporates advances in the field since 1992 and contains new chapters. Annotation c. by Book News, Inc., Portland, Or.

Now available in its Third Edition, Asthma: Basic Mechanisms and Clinical Management has become the reference text in asthma. This highly successful text sheds new light on the basic physiological and molecular mechanisms of asthma, how current treatments work, and how best to apply the latest knowledge to control this important disease. The Third Edition has undergone radical revision and includes several new chapters. It retains the virtues of the previous volumes by bringing together all of the recent research findings by internationally recognized experts on the causative mechanisms of asthma, including in-depth clinical aspects and therapy. The book presents an integrated approach toward the treatment of this disease with new concepts, changes in asthma management, and the development of new therapeutic agents. Asthma provides extensive references for researchers and clinicians who need to keep abreast of recent developments in this rapidly expanding field.

Key Features
* Comprehensive coverage of both basic science and clinical aspects of asthma
* Extensively referenced throughout

Recenzijas

Reviews of the Second Edition"This book is clearly written... each chapter is extensively referenced and as up to date as possible... essential reading for academics and researchers in the field of asthma." --RESPIRATORY MEDICINE"This is still the only book on asthma that brings together recent information on basic mechanisms and covers in depth clinical aspects and therapy." --TRENDS IN PHARMACOLOGICAL SCIENCES

Papildus informācija

Key Features * Comprehensive coverage of both basic science and clinical aspects of asthma * Extensively referenced throughout



Peter Barnes is Professor of Thoracic Medicine at the National Heart and Lung Institute, Head of Respiratory Medicine at Imperial College and Honorary Consultant Physician at Royal Brompton Hospital, London. He qualified at Cambridge and Oxford Universities was appointed to his present post in 1987. He has published over 1000 peer-review papers on asthma, COPD and related topics and has edited over 40 books. He is also amongst the top 50 most highly cited researchers in the world and has been the most highly cited clinical scientist in the UK and the most highly cited respiratory researcher in the world over the last 20 years. He was elected a Fellow of the Royal Society in 2007, the first respiratory researcher for over 150 years. He is currently a member of the Scientific Committee of the WHO/NIH global guidelines on asthma (GINA) and COPD (GOLD). He also serves on the Editorial Board of over 30 journals and is currently an Associate Editor of Chest and respiratory Editor of PLoS Medicine. He has given several prestigious lectures, including the Amberson Lecture at the American Thoracic Society and the Sadoul Lecture at the European Respiratory Society. Neil Thomson is Professor of Respiratory Medicine at the University of Glasgow, Head of Respiratory Medicine within the Division of Immunology, Infection & Inflammation and Honorary Consultant at Gartnavel General Hospital, Glasgow. He graduated from the University of Glasgow and undertook postgraduate training in Glasgow, London and McMaster University, Canada. He is a former member of the Committee for Safety of Medicine and former Chair of the Scientific Committee of the British Lung Foundation. He has co-edited several textbooks on asthma and COPD and published over 150 peer-reviewed papers on asthma. His current research interests include corticosteroid insensitivity in smokers with asthma, biomarkers in asthma and COPD and assessment of novel treatments for asthma.